Edition:
United Kingdom

Kopin Corp (KOPN.OQ)

KOPN.OQ on NASDAQ Stock Exchange Global Select Market

1.03USD
16 Aug 2019
Change (% chg)

$0.06 (+6.19%)
Prev Close
$0.97
Open
$0.98
Day's High
$1.03
Day's Low
$0.98
Volume
59,918
Avg. Vol
179,120
52-wk High
$2.45
52-wk Low
$0.96

Summary

Name Age Since Current Position

John Fan

74 1990 Chairman of the Board, President, Chief Executive Officer

Richard Sneider

57 2015 Chief Financial Officer, Treasurer

Bor-Yeu Tsaur

62 1997 Executive Vice President - Display Operations

Hong Choi

63 2000 Chief Technology Officer, Vice President

Paul Baker

56 2019 Strategic Business Officer

David Brook

77 2010 Secretary, Independent Director

Morton Collins

83 2014 Lead Independent Director

James Brewington

74 2006 Independent Director

Andrew Chapman

63 1985 Independent Director

Chi Chia Hsieh

73 1995 Independent Director

Michael Landine

64 2003 Independent Director

Biographies

Name Description

John Fan

Dr. John C.C. Fan, Ph.D., is Chairman of the Board, President, Chief Executive Officer of Kopin Corp. Dr. Fan has served as our Chief Executive Officer and Chairman of the Board since our organization in April 1984. He has also served as our President since July 1990. Prior to July 1985, Dr. Fan was Associate Leader of the Electronic Materials Group at MIT Lincoln Laboratory. Dr. Fan is the author of numerous patents and scientific publications. Dr. Fan received a Ph.D. in Applied Physics from Harvard University. During the past five years, Dr. Fan has not served on the board of directors of any other public companies or registered management investment companies.

Richard Sneider

Mr. Richard A. Sneider is Chief Financial Officer and Treasurer of Kopin Corp. since September 1998. Mr. Sneider has served as our Treasurer and Chief Financial Officer since September 1998. Mr. Sneider is a former Certified Public Accountant and was formerly a partner of the international public accounting firm, Deloitte & Touche LLP, where he worked for 16 years.

Bor-Yeu Tsaur

Dr. Bor-Yeu Tsaur, Ph.D., is Executive Vice President - Display Operations of Kopin Corp. since July 1997. He joined us as Executive Vice President—Display Operations in July 1997. From 1993 to 1997, Dr. Tsaur served as Group Leader, Electronic Material Group, at MIT Lincoln Laboratory. Dr. Tsaur received a Ph.D. in Electrical Engineering from the California Institute of Technology.

Hong Choi

Dr. Hong Choi, Ph.D., is Chief Technology Officer, Vice President of Kopin Corp. since July 2000. Previously, Dr. Choi served as Senior Staff Member at MIT Lincoln Laboratory, where he worked for 17 years. Dr. Choi received a Ph.D. in Electrical Engineering from the University of California, Berkeley.

Paul Baker

Mr. Paul Baker is Strategic Business Officer of the Company. He previously served as the Company’s Senior Vice President, Business Development since January 2017, and as Vice President, Business Development between March 2014 and December 2016. From 2007 to 2014, Mr. Baker served as Executive Vice President, Business Development & Sales at ZINK Imaging Co., a privately-held company headquartered in Billerica, Massachusetts that invented ZINK Zero Ink® Technology. Mr. Baker holds a B.A. in economics from Colby College and a M.B.A. from Boston University.

David Brook

Mr. David E. Brook is Secretary, Independent Director of Kopin Corp. since 1984. Mr. Brook has served as one of our directors since 1984. Mr. Brook is a founder and principal of the intellectual property law firm Hamilton, Brook, Smith & Reynolds P.C. in Boston and Concord, Massachusetts. During the past five years, Mr. Brook has not served on the board of directors of any other public companies or registered management investment companies.

Morton Collins

Dr. Morton Collins, Ph.D., is Lead Independent Director of Kopin Corp., since 1985. Mr. Collins has served as one of our directors since 1985 and was elected our Lead Independent Director in 2014. Mr. Collins received his PhD in Chemical Engineering from Princeton University and his PhD in Science from University of Delaware. From October 1968 to June 1974, Mr. Collins was the Founder and Chief Executive Officer of Data Science Ventures, Inc. (DSV I). He was a Founder of DSV Associates (DSV II); DSV Partners III (DSV III); DSV Partners IV (DSV IV) and has been the Managing Partner of each since their formation in 1974, 1981 and 1985 respectively. These organizations provide venture capital and management assistance to early-stage high-technology companies. In July of 1997, Mr. Collins became a Special Limited Partner of Cardinal Partners, the successor to the DSV series of partnerships. From 2003 to 2016, Mr. Collins was a General Partner of Battelle Ventures. In January of 2017, Mr. Collins founded M Collins Ventures, a venture capital fund of which he is the Managing Partner. Mr. Collins is currently a member of the board of directors of Inovio Pharmaceuticals, Inc., a public company. During the past five years, Mr. Collins has not served on the board of directors of any other public companies or registered management investment companies other than Inovio.

James Brewington

Mr. James K. Brewington is Independent Director of Kopin Corp. since 2006. Mr. Brewington has served as one of our directors since 2006. Mr. Brewington retired as President of Developing Markets at Lucent Technologies in 2007. Prior to heading Lucent’s Developing Markets group, Mr. Brewington served as president of that company’s Mobility Solutions Group, where he was responsible for all wireless infrastructure for the mobility segment, including global wireless development and product architecture, project management, and business and product management. He began his career at AT&T in 1968, and over the ensuing years he has held various executive management positions in the telecommunications industry, including overseeing Bell Telephone Wireless Laboratories. Mr. Brewington is currently chairman of the Board of directors of New Edge Signal Solutions, a private company. During the past five years,

Andrew Chapman

Mr. Andrew H. Chapman is independent Directors of Kopin Corp. since 1985. Mr. Chapman has served as one of our directors since 1985. From 2003 to the present, Mr. Chapman has been a private investor. Mr. Chapman has founded, managed, been a director of and/or invested in numerous technology start-up companies over the past 20 years. Mr. Chapman received a B.A. from Yale College and an MBA from The Wharton School of the University of Pennsylvania. During the past five years, Mr. Chapman has not served on the board of directors of any other public companies or registered management investment companies.

Chi Chia Hsieh

Dr. Chi Chia Hsieh is Independent Director of Kopin Corp., since December 1995. Dr. Hsieh is currently the Vice Chairman and was previously the President of Microelectronics Technology Inc., a Taiwan corporation publicly traded on the Taiwan Stock Exchange. Dr. Hsieh is Chairman of the board of directors of IQE Taiwan, a Taiwan corporation in which we formerly were a majority stockholder until January 2013. Dr. Hsieh is also a member of the board of directors of BriteLED, a Taiwan Corporation publicly traded on the Taiwan Stock Exchange. Dr. Hsieh is currently a member of the board of directors of Microelectronics Technology Inc., Advanced Wireless Systems, Bright LED Electronics Corp., and Taiwan Cement Corporation, all public companies. Dr. Hsieh is also the Independent Director of Innolux Corporation, and Independent Director of AcBel Polytech Inc., both are public companies in Taiwan. During the past five years, Dr. Hsieh has not served on the board of directors of any other public companies or registered management investment companies.

Michael Landine

Mr. Michael J. Landine is Independent Director of Kopin Corp. since 2003. Mr. Landine is Senior Vice President of Corporate Development of Alkermes, Inc., where he has worked for over 20 years. Mr. Landine served for 10 years as the Chief Financial Officer and Treasurer of Alkermes. Mr. Landine worked for the international accounting firm Touche Ross & Co. During the past five years, Mr. Landine has not served on the board of directors of any other public companies or registered management investment companies other than GTC Biotherapeutics Inc., a publicly-traded biotechnology company, from 2005 to 2010.

Basic Compensation